References
[1] M. Hrubisko, R. Danis, M. Huorka, and M. Wawruch, “Histamine Intolerance-The More We Know the Less We Know. A Review,” Nutrients, vol. 13, no. 7, p. 2228, Jun. 2021, doi: 10.3390/nu13072228.
[2] K. N. Dileepan et al., “Mast cell-mediated immune regulation in health and disease,” Front. Med., vol. 10, p. 1213320, 2023, doi: 10.3389/fmed.2023.1213320.
[3] C. Prinz, R. Zanner, and M. Gratzl, “Physiology of gastric enterochromaffin-like cells,” Annu. Rev. Physiol., vol. 65, pp. 371–382, 2003, doi: 10.1146/annurev.physiol.65.092101.142205.
[4] T. Yoshikawa, T. Nakamura, and K. Yanai, “Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness,” Br. J. Pharmacol., vol. 178, no. 4, pp. 750–769, Feb. 2021, doi: 10.1111/bph.15220.
[5] Z. Mou, Y. Yang, A. B. Hall, and X. Jiang, “The taxonomic distribution of histamine-secreting bacteria in the human gut microbiome,” BMC Genomics, vol. 22, no. 1, p. 695, Sep. 2021, doi: 10.1186/s12864-021-08004-3.
[6] S. Sánchez-Pérez et al., “Intestinal Dysbiosis in Patients with Histamine Intolerance,” Nutrients, vol. 14, no. 9, p. 1774, Apr. 2022, doi: 10.3390/nu14091774.
[7] S. Sánchez-Pérez, O. Comas-Basté, J. Rabell-González, M. T. Veciana-Nogués, M. L. Latorre-Moratalla, and M. C. Vidal-Carou, “Biogenic Amines in Plant-Origin Foods: Are They Frequently Underestimated in Low-Histamine Diets?,” Foods Basel Switz., vol. 7, no. 12, p. 205, Dec. 2018, doi: 10.3390/foods7120205.
[8] I. San Mauro Martin, S. Brachero, and E. Garicano Vilar, “Histamine intolerance and dietary management: A complete review,” Allergol. Immunopathol. (Madr.), vol. 44, no. 5, pp. 475–483, 2016, doi: 10.1016/j.aller.2016.04.015.
[9] M. E. Parsons and C. R. Ganellin, “Histamine and its receptors,” Br. J. Pharmacol., vol. 147 Suppl 1, no. Suppl 1, pp. S127-135, Jan. 2006, doi: 10.1038/sj.bjp.0706440.
[10] Y. Ji et al., “Lymphatic diamine oxidase secretion stimulated by fat absorption is linked with histamine release,” Am. J. Physiol. Gastrointest. Liver Physiol., vol. 304, no. 8, pp. G732-740, Apr. 2013, doi: 10.1152/ajpgi.00399.2012.
[11] L. Maintz et al., “Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities,” Allergy, vol. 66, no. 7, pp. 893–902, Jul. 2011, doi: 10.1111/j.1398-9995.2011.02548.x.
[12] L. Maintz and N. Novak, “Histamine and histamine intolerance,” Am. J. Clin. Nutr., vol. 85, no. 5, pp. 1185–1196, May 2007, doi: 10.1093/ajcn/85.5.1185.
[13] M. Schink et al., “Microbial patterns in patients with histamine intolerance,” J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc., vol. 69, no. 4, Aug. 2018, doi: 10.26402/jpp.2018.4.09.
[14] A. Rosell-Camps, S. Zibetti, G. Pérez-Esteban, M. Vila-Vidal, L. Ferrés-Ramis, and E. García-Teresa-García, “Histamine intolerance as a cause of chronic digestive complaints in pediatric patients,” Rev. Esp. Enferm. Dig., vol. 105, no. 4, pp. 201–206, Apr. 2013, doi: 10.4321/s1130-01082013000400004.
[15] R. Meza-Velázquez et al., “Association between two polymorphisms of histamine-metabolising enzymes and the severity of allergic rhinitis in a group of Mexican children,” Allergol. Immunopathol. (Madr.), vol. 44, no. 5, pp. 433–438, 2016, doi: 10.1016/j.aller.2016.01.002.
[16] A. Szczepankiewicz, A. Bręborowicz, P. Sobkowiak, and A. Popiel, “Polymorphisms of two histamine-metabolizing enzymes genes and childhood allergic asthma: a case control study,” Clin. Mol. Allergy CMA, vol. 8, p. 14, Nov. 2010, doi: 10.1186/1476-7961-8-14.
[17] W. J. Schnedl, H. Mangge, M. Schenk, and D. Enko, “Non-responsive celiac disease may coincide with additional food intolerance/malabsorption, including histamine intolerance,” Med. Hypotheses, vol. 146, p. 110404, Jan. 2021, doi: 10.1016/j.mehy.2020.110404.
[18] Y. Honzawa, H. Nakase, M. Matsuura, and T. Chiba, “Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability,” Inflamm. Bowel Dis., vol. 17, no. 2, pp. E23-25, Feb. 2011, doi: 10.1002/ibd.21588.
[19] I. Reese et al., “Guideline on management of suspected adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergology and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA) as well as the Swiss Society for Allergology and Immunology (SGAI) and the Austrian Society for Allergology and Immunology (ÖGAI),” Allergol. Sel., vol. 5, pp. 305–314, 2021, doi: 10.5414/ALX02269E.
[20] V. Cucca et al., “Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study,” Nutrients, vol. 14, no. 7, p. 1513, Apr. 2022, doi: 10.3390/nu14071513.
[21] J. van Odijk, A. Weisheit, M. Arvidsson, N. Miron, B. Nwaru, and L. Ekerljung, “The Use of DAO as a Marker for Histamine Intolerance: Measurements and Determinants in a Large Random Population-Based Survey,” Nutrients, vol. 15, no. 13, p. 2887, Jun. 2023, doi: 10.3390/nu15132887.
[22] K. Arih, N. Đorđević, M. Košnik, and M. Rijavec, “Evaluation of Serum Diamine Oxidase as a Diagnostic Test for Histamine Intolerance,” Nutrients, vol. 15, no. 19, p. 4246, Oct. 2023, doi: 10.3390/nu15194246.
[23] L. Kofler, H. Ulmer, and H. Kofler, “Histamine 50-skin-prick test: a tool to diagnose histamine intolerance,” ISRN Allergy, vol. 2011, p. 353045, 2011, doi: 10.5402/2011/353045.
[24] W. U. Schmidt et al., “Human intestinal diamine oxidase (DAO) activity in Crohn’s disease: a new marker for disease assessment?,” Agents Actions, vol. 30, no. 1–2, pp. 267–270, Apr. 1990, doi: 10.1007/BF01969057.
[25] P. Komericki et al., “Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomised, double-blind, placebo-controlled cross-over study,” Wien. Klin. Wochenschr., vol. 123, no. 1–2, pp. 15–20, Jan. 2011, doi: 10.1007/s00508-010-1506-y.
[26] S. Wöhrl, W. Hemmer, M. Focke, K. Rappersberger, and R. Jarisch, “Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine,” Allergy Asthma Proc., vol. 25, no. 5, pp. 305–311, 2004.
[27] B. Giera, S. Straube, P. Konturek, E. G. Hahn, and M. Raithel, “Plasma histamine levels and symptoms in double blind placebo controlled histamine provocation,” Inflamm. Res. Off. J. Eur. Histamine Res. Soc. Al, vol. 57 Suppl 1, pp. S73-74, 2008, doi: 10.1007/s00011-007-0636-9.
[28] J. Izquierdo-Casas et al., “Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trial,” Clin. Nutr. Edinb. Scotl., vol. 38, no. 1, pp. 152–158, Feb. 2019, doi: 10.1016/j.clnu.2018.01.013.
[29] M.-R. Yacoub et al., “Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study,” Int. Arch. Allergy Immunol., vol. 176, no. 3–4, pp. 268–271, 2018, doi: 10.1159/000488142.
[30] W. J. Schnedl, M. Schenk, S. Lackner, D. Enko, H. Mangge, and F. Forster, “Diamine oxidase supplementation improves symptoms in patients with histamine intolerance,” Food Sci. Biotechnol., vol. 28, no. 6, pp. 1779–1784, Dec. 2019, doi: 10.1007/s10068-019-00627-3.
[31] W. Barcik et al., “Histamine-secreting microbes are increased in the gut of adult asthma patients,” J. Allergy Clin. Immunol., vol. 138, no. 5, pp. 1491-1494.e7, Nov. 2016, doi: 10.1016/j.jaci.2016.05.049.